| Name | (2E)-2-(4-Bromobenzylidene)-N-(2,6-dimethylphenyl)hydrazinecarboxamide |
|---|---|
| Synonyms |
(2E)-2-(4-Bromobenzylidene)-N-(2,6-dimethylphenyl)hydrazinecarboxamide
Hydrazinecarboxamide, 2-[(4-bromophenyl)methylene]-N-(2,6-dimethylphenyl)-, (2E)- MFCD28118904 |
| Description | EGA is a selective inhibitor of endosomol trafficking pathways exploited by multiple toxins and virus[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C16H16BrN3O |
| Molecular Weight | 346.222 |
| Exact Mass | 345.047668 |
| LogP | 5.38 |
| Index of Refraction | 1.609 |
| Symbol |
GHS07, GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335-H410 |
| Precautionary Statements | P261-P273-P305 + P351 + P338-P501 |
| RIDADR | UN 3077 9 / PGIII |